TL;DR
- iPledge is the FDA's mandatory risk-management program for isotretinoin (Accutane®).
- Every U.S. patient — male or female — must enroll before starting and check in every month.
- The prescription window depends on your iPledge category: 7 days from your pregnancy-test draw date if you can get pregnant, 30 days from the office-visit date your prescriber enters if you cannot, a window that goes away on November 15, 2026. Miss it and you wait for the next cycle.
- Before your first prescription, the second pregnancy test is a lab test at least 30 days after your dermatologist confirms your screening test in iPledge, taken in the first 5 days of your period (no period: your dermatologist confirms the exception and you test any day once eligible). After that, one test each month.
- The FDA approved iPledge changes in February 2026 — including elimination of the 19-day lockout — with implementation delayed to November 15, 2026.
- TGIC's iPledge concierge tracks every window, test, and refill for you.
What iPledge is, in plain English
iPledge is the FDA-mandated program that controls who can receive isotretinoin (Accutane®) and when. It exists because isotretinoin causes severe, predictable birth defects if taken during pregnancy. The program is the FDA's way of making sure no patient starts Accutane® pregnant and no patient becomes pregnant during treatment.
Three parties have to participate every month: the patient, the prescriber, and the pharmacy. All three log into iPledge, confirm the patient is still eligible to receive the drug, and only then does the pharmacy release the next month's supply.
The monthly window
How long the window runs depends on your iPledge category. If you can get pregnant, each monthly pregnancy test opens a 7-day window, counted from the date the specimen was collected. If you cannot get pregnant, the window is currently 30 days, counted from the office-visit date your prescriber enters, and that window goes away entirely on November 15, 2026. Either way the patient completes their monthly step (the comprehension questions if you can get pregnant, an attestation if you cannot), the prescriber authorizes, and the pharmacy dispenses inside the window. Miss it and the prescription voids. You don't lose your spot in the program, but you lose that month of treatment.
This is the single most frustrating mechanic in the program. It's why dermatologists who don't specialize in Accutane® often refuse to prescribe it: the operational load is real, and missed windows mean delayed treatment.
Pregnancy testing cadence
Patients who can get pregnant complete pregnancy testing in two parts:
- A screening test when your dermatologist decides to prescribe. Then a confirmation lab test at least 30 days after your dermatologist confirms that screening test in iPledge — taken during the first 5 days of your period. If you don't get a period (amenorrhea, irregular cycles, or a contraceptive that stops withdrawal bleeding), your dermatologist confirms the exception and you test any day once you're eligible.
- The draw date of that confirmation test starts the 7-day window to fill the prescription.
- One negative test each month during treatment, before each refill.
- A test right after your last dose, the first of two post-treatment tests.
- A final test 30 days after your last dose. Keep both birth control methods going through that month.
Patients who cannot get pregnant have no monthly test or form of their own. Until November 15, 2026, their prescriber confirms counseling in iPledge each month, and that month's prescription can't be released until that step is done. Their only iPledge step is enrollment.
What's changing November 15, 2026
The FDA approved updates to the iPledge REMS program in February 2026, originally set for August. In June 2026 the FDA delayed implementation to November 15, 2026 to allow more system testing. When they take effect, the changes include:
- 19-day lockout eliminated. Today, a patient who can get pregnant and misses that first 7-day window before starting treatment waits at least 19 days before testing again. After the cutover the repeat confirmatory test is done without a waiting period. It is still a medical-setting test, which for a telehealth patient means a lab.
- Home pregnancy tests become the prescriber's call. A prescriber may accept tests taken outside a medical setting after the first dose of a course, and has to run a process that minimizes misread and falsified results. Both pre-treatment tests stay in a medical setting, which for a telehealth patient means a lab.
- The prescription clock ends for patients who cannot get pregnant. Pharmacies stop receiving a "Do Not Dispense To Patient After Date" for that category, so the current 30-day window no longer applies. The 30-day maximum supply stays.
- Monthly counseling documentation drops to enrollment only for patients who cannot get pregnant.
- Patient materials change. The Fact Sheet leaves the REMS and a Guide for Patients Who Cannot Get Pregnant replaces it, alongside two new Pregnancy Registry guides.
TGIC's iPledge concierge tracks both rule sets and switches automatically on the implementation date. Until November 15, current rules apply; patients mid-course transition with their dermatologist.
What happens if you miss a window
The current month's prescription voids. You wait for the next monthly cycle to open, complete the check-in and (if applicable) a new pregnancy test, and resume. You don't lose your overall eligibility — you lose a month of treatment.
The most common reason patients miss windows: they didn't know the window was open, or didn't know when it was about to close. That's the operational chaos TGIC's concierge exists to prevent. Every window-open and window-closing event triggers an alert, and you can see the live window state in your dashboard.
Not enrolled yet? Here is how to start Accutane® online. What the monthly cadence, labs, and medication cost: Accutane® cost & insurance.
Common questions
What is iPledge and why does Accutane® require it?
iPledge is the FDA's risk-management program for isotretinoin (Accutane®). It exists because isotretinoin causes severe birth defects if taken during pregnancy, so every U.S. patient — male or female — must enroll before starting and check in every month of treatment. iPledge tracks pregnancy tests, monthly authorization windows, and prescription deadlines.
How does the iPledge monthly window work?
How long the iPledge monthly window runs depends on your patient category. If you can get pregnant, it is a 7-day prescription window and the draw date of your pregnancy test opens it. If you cannot get pregnant, it is currently 30 days, counted from the office-visit date your prescriber enters, and that window is removed on November 15, 2026. Either way the prescription has to be filled before the window closes. During treatment, patients who can get pregnant do one negative pregnancy test each month; patients who can't get pregnant have no monthly step of their own, and until November 15, 2026 their prescriber confirms counseling in iPledge each month before the prescription is released. Before your very first prescription the timing is stricter: the second test is a lab test taken at least 30 days after your dermatologist confirms your screening test in iPledge, and it has to fall in the first 5 days of your period. If you don't get a period — amenorrhea, irregular cycles, or birth control that stops withdrawal bleeding — your dermatologist confirms the exception and you can test any day once the 30 days have passed. Miss your window and the prescription resets. TGIC's iPledge concierge tracks every date for you.
What happens if I miss my iPledge window?
If you miss your iPledge prescription window (7 days from your test draw date if you can get pregnant, currently 30 days from the office-visit date if you cannot), the current prescription voids and you wait for the next monthly window to open. You don't lose your spot in the program, but you lose that month of treatment. TGIC sends window-open alerts, refill reminders, and a heads-up before the window closes — keeping the chaos out of the program is the whole reason the concierge exists.
Did iPledge rules change in 2026?
Yes — and the timing recently moved. The FDA approved changes to the iPledge REMS program in February 2026 (including elimination of the 19-day wait a patient who can get pregnant now serves after missing that first prescription window before treatment starts, removal of the prescription window for patients who cannot get pregnant, and home pregnancy tests after the first dose at the prescriber's discretion), but in June 2026 the FDA delayed implementation to November 15, 2026 to allow more system testing. Until then, the current rules apply. TGIC's iPledge concierge tracks both rule sets and switches automatically on the implementation date — you never have to keep score.
Do I have to take birth control to get Accutane®? What if I can't or won't?
This is federal law, not a clinic policy. Isotretinoin causes severe birth defects, so the FDA boxed warning requires anyone who can become pregnant to use two forms of contraception at the same time, at least one of them a primary method, starting one month before the first dose, through treatment, and for one month after the last dose. The label names three exceptions: continuous abstinence, a hysterectomy or removal of both ovaries, and medically confirmed menopause. iPledge also requires pregnancy tests before the first prescription, one every month before each refill, and after the course ends. If you cannot get pregnant for one of those medical reasons, iPledge puts you in a different category with no monthly tests or contraception rules. Until November 15, 2026, your prescriber confirms counseling in the program each month instead; after that date counseling is documented at enrollment only. A tubal ligation does not qualify for that category. If you can become pregnant and will not use contraception, abstinence is the path the program allows, and your dermatologist documents it. Planning a pregnancy afterward: the two-forms rule runs for one month past your last dose, so that month is the earliest to start trying. TGIC's iPledge concierge tracks every test date and prescription window for you.
Sources: FDA Accutane® prescribing information (DailyMed), MedlinePlus, isotretinoin, iPledge REMS program
Keep reading
Cost and insurance
Pricing for The Clear Course, what insurance covers, how prescriptions are billed, HSA and FSA receipts, and what labs cost.
Accutane® (isotretinoin)
How Accutane® works through TGIC, low-dose protocols, side effects, course length, and how it compares to topicals like tretinoin.
States and eligibility
Where TGIC operates, who can enroll, conditions covered, and how teen consent works.
How it works
The dermatologist, the quiz, results timeline, cancel terms, HIPAA, and how TGIC differs from other online services.